VKTX — Viking Therapeutics Share News
0.000.00%
Last trade - 00:00Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
U.S. STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
US STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
U.S. STOCKS ON THE MOVE-CoreWeave, Versant Media, BlackBerry
U.S. STOCKS ON THE MOVE-Everpure, Dropbox, Darden Restaurants
Brief: Viking Therapeutics Prices Upsized $500 Million Offering Of Common Stock And Convertible Senior Notes
Viking Therapeutics falls on $275 mln stock, $225 mln convertible deals
Brief: Viking Therapeutics Announces Proposed Offerings Of Common Stock And Convertible Senior Notes
Viking Therapeutics slips on planned stock, convertible offerings
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
U.S. STOCKS ON THE MOVE-Greenland Mines, GameStop, Shopify
U.S. STOCKS ON THE MOVE-Vicor, Thor Industries, Lennar
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Viking Therapeutics jumps after experimental drug shows durable weight-loss benefit
Viking Therapeutics' obesity drug shows durable weight-loss benefit, shares surge (updated)
Viking Therapeutics' obesity drug shows 22% weight loss in study
Brief: Viking Therapeutics Announces Positive Topline Results From Maintenance Study Of Glp-1/Gip Agonist Vk2735 Demonstrating The Promise Of Multiple Maintenance Dosing Regimens
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Viking Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary